Lexeo Therapeutics, Inc. (LXEO) Share-based Compensation (2022 - 2023)
Lexeo Therapeutics' Share-based Compensation history spans 2 years, with the latest figure at $804000.0 for Q4 2023.
- For Q4 2023, Share-based Compensation changed N/A year-over-year to $804000.0; the TTM value through Dec 2023 reached $3.0 million, changed N/A, while the annual FY2024 figure was $12.5 million, 309.92% up from the prior year.
- Share-based Compensation for Q4 2023 was $804000.0 at Lexeo Therapeutics, down from $873000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $969000.0 in Q2 2023 and bottomed at $397000.0 in Q1 2023.